PHARMA calcium and bone homeostasis Flashcards
amt of calcium in averagediet
600-1000 mg
functions of bone
mineral reservoir
structural support
hematopoiesis
principal regulatoes
PTH
FGF 23
Steroid vitamin d
secondary regulators
calcitonin prolactin gh insulin
thyroid hormone, glucocorticoids, sex strroids
function of fgf 23
stimulates RENAL PO4 EXCRETION
what increases serum calcium and decrease serum phosphate
acts on bone and kidney
PTH
action of pth on bone
inc osteoclast activity by inducing RANK ligand (for bone REMODELING)
effect of low and intermittent PTH on bine
increase bone FORMATION
recombinant PTH 1-34
TERIPARATIDE
effect of pth on kidney
reabsorb calcium and magnesium
stimulate vit d production
forms of vit d
vit d3 cholecalciferol NATURAL
vit d2 ergocalciferol PLANT DERIVED
forms of vit d in liverr and kidney
liver 25OHD
kidney 1,25OH2D
kidney 24,24 OH 2D
calcifediol
calcitriol
secalcifediol
25 OH d3
1,25 oh 2D3
24,25 oh 2D3
give 3 vitamin d analogs
calcipotriene
doxercalciferol
paricalcitol
tx for psoriasis
CALCIPOTRIENE vit d analog
tx for 2ndary hyperparathyroidism
DOXERCALCIFEROL and PARACALCITOL vit d analogs
what inhibits and stimulates vit d metabolism
fgf23 inhibits
pth stimulates
which vit d is most potent and has low affinity
CALCITRIOL
calcifediol vs calcitriol
calcifediol more potent in stimulating renal reabsorption of ca and po4
pth regulated by feedback loops through?
calcium sensing receptors
directly inhibits PTH secretion
1,25(OH)2D
stimulates production of FGF23
1,25(OH)2D
inhibits 1,25(OH)2D production
FGF23
inhibit PTH secretion
Calcitriol analogs
mgmt of secondary hyperparathyroidism of CKD
Calcitriol analogs
Parafollicular cells of mammalian thyroid
Calcitonin
calcitonin half life
10mins
longer halflife, reduced metabolic clearance
salmon calcitonin
lowers Ca and PO4 reabsorption, dec GASTRIN secretion
calcitonin
potent stimulus for calcitonin secretion
Pentagastrin
block bone resorption and lower serum calcium
calcitonin
physiologic use of calcitonin
Paget’s disease, Hypercalcemia, Osteoporosis
Glucocorticoid use
stimulates renal calcium excretion
antagonizes vit D transport
blocks bone formation
hypercalcemia associated with inc production of 1,25(OH)2D
Granulomatous diseases - Sarcoidosis
Estrogen
prevent accelerated bone loss in post menopausal women
reduce bone resorption
inc 1,25(OH)2D
Selective estrogen receptor modulators
breast, uterus, cardiovascular system
newer therapies for osteoporosis
no risk of breast and endometrial ca
raloxifene
Bisphosphonates
osteoclast apoptosis
inhibition of cholesterol pathway
amino bisphosphonates
Alendronate and risedronate
block farnesyl pyrophosphate synthase
amino bisphosphonates
First generation bisphosphonates
MEDronate
ETIdronate
CLODronate
second generation bisphosphonates
ALEdronate
PAMidronate
3rd generation bisphosphonates
RISEdronate
ZolEDdronate
10,000x more potent than 1st gen
All current available bisphosphonate hav this complication
Gastric irritation (possible exception of ETIdronate)
main contraindication of bisphosphonates
dec renal dunction
esophageal motility disorders
peptic ulcer disease
physiologic use of bisphosphonates
hypercalcemia
paget’s disease
osteoporosis
bone metastasis
mineralization defect SE
ETIdronate
gastric and esophageal irritation SE
PAMidronate
high doses of ALEdronate
high doses of IV ZolEDronate SE
ONJ osteonecrosis of the jaw
Recombinant form of PTH stim bone formation
TERIparatide -
activates CaSR and blocks PTH secretion
Cinacalcet
Cinacalcet Tx
Secondary hyperPTH of CKD
Parathyroid carcinoma
cytotoxic antibody
binds to DNA and interrupts RNA synthesis
PLICAmycin
Thiazide use
reduces renal calcium excretion
block sodium reabsorption
inc Ca-Na exchange
reduces stone formation
decrease urine oxalate
increase urine Mg and Zinc
Thiazides
fluoride without adequate calcium produces
Osteomalacia
Blocks osteoclast differentiation while promoting their apoptosis
Strontium Ranelate
bone formation markers
inc bone density
dec fractures
Strontium Ranelate
for mgmt of hypercalcemia of malignancy
inhibits bone formation
potential nephrotoxic
Gallium Nitrate
major causes of hypercalcemia
thiazide therapy
hyperPTH
Cancer
less common cause of hypercalcemia
hypervitaminosis D
for syptomatic hypercalcemia
Saline Diuresis with furosemide
Tx for hypercalcemia of malignancy
has self-limited flu-like symptoms
PAMidronate
ZolEDronate
parentral and nasal administration of Salmon Calcitonin
ANCILLARY Tx
Calcimar
most dangerous SE of sudden thrombocytopenia followed by hemorrhage
PLICAmycin
“when all else fail”
PLICAmycin
fastest and surest way for hypercalcemia
IV phosphate
for chronic hypercalcemia of sarcoidosis, vit D intoxication etc
Glucocorticoids
Major causes of hypocalcemia in adult
hypoparathyroidism
vit D deficiency
CKD
Malabsoprtion
mainstay Tx for hypocalcemia
calcium and vitamin D
Calcium forms
Calcium gluceptate
Calcium GLUCOnate (preferred)
Calcium chloride
Oral preparation of Calcium
Ca carbonate (40%) Ca phosphate (25%) Ca citrate (21%) Ca lactate (13%)
Ca carbonate should be given with meals
or Ca citrate alternative
Achlorydic patients
Tx for severe symtomatic hypocalcemia
5-20ml 10% calcium gluconate (slow infusion)
Vit D metabolite of choice
raises serum PO4
Calcitriol
Hyperphosphatemia symptoms
common complication of renal failure
vit D intoxication
hypoPTH
rare Tumoral calcinosis
phosphate-binding gel
SEVELAMER
hypophosphatemia related diseases
Vit D Deficiency
hypophosphatemic rickets
FANCONIs SYNDROME (renal wasting)
Reduced ATP
Decreased 2,3DPG
rhabdomyolysis
acute hypophosphatemia effects
For hypercalcemia
Saline + furosemide bisphosphonate calcitonin plicamycin phosphate IV - fastest glucocorticoid - cancer
for hypocalcemia
Calcium gloconate IV
Calcium CO3PO
Calcitriol - RAPID
for hyperphosphatemia
PO4 restriction SEVELAMER Calcium Aluminum antacid* Dialysis
for hypophosphatemia
oral phosphate suppplment
Best Tx for HyperPTH
Surgery
Causes of HypoPTH
absence of PTH
abnormal target tissue response (pseudohoPTH)
nor mal or high PTH acting on the bone not kidneys
pseudohypoPTH
pseudohypoPTH causes
osteitis fibrosa
optimum level of 25(OH)D
30ng/mL
daily intake of Vit D
800-1200 units of vit D
effect of CKD in bone
Osteomalacia and Osteitis fibrosa
Tx for adynamic bone disease in CKD
DEFEROXAMINE
Analongs of calcitriol
DOXercalciferol
PARIcalcitriol
advantage of calcitriol analogs
less likely to induce HYPERGLYCEMIA
characterized by malabsorption of ca and vit d
and combined osteoporosis and osteomalacia
intestinal osteodystrophy
intestinal vs renal osteodystrophy
no osteitis fibrosa in intestinal dystrophy
tx for mild and severe int. osteodystrophy
mild vit d
severe calcitriol
causes of osteoporosis in men
chronic glucocorticoids thyrotoxicosis and hyperparathyroidism malabsorption alcohol abuse cigarette smoking isionpathic
osteoporosis tx in postmenopausal women, may be accompanied by lower calcitriol?
estrogen cycled with progestin
serm for osteoporosis, preventing risk of breast and uterine cancer
RALOXIFENE
Raloxifene adverse effect
inc risk of thrombophlebitis
raloxifene clinical actions
protects against spine BUT NOT hip fractures
cant prevent HOT FLUSHES
recombinant pth
approved for use for ONLY 2 YEARS in sequential therapy
TERIPARATIDE
bisphosphonate for osteoporosis action
reduce risk of HIP SPINE AND OTHER fractures
for MEN AND WOMEN
toxicities of adjuvant endocrine tx
loss of BMD
bone fracture
osteoporosis
musculoskeletal / arthralgia
used for bmd assessment, from lumbar spine of one or both total hip sites
DXA scan
tx for high risk group of BMD (baseline score of <-2)
BISPHOSPHONATE therapy
calcitonin action on osteoporisis
affects only the SPINE
antibody to RANKL, for osteoporosis
DENOSUMAB
denosumab adverse effects
possible inc risk for infection
risk of OSTEONECROSIS OF JAW
subtrochanteric fractures
slow release, low dose tx for osteoporosisl
fluoride
loss of vit d binding protein, some develop bone disease
nephrotic syndrome
vit d dependent rickets type i and ii
type i - pseudovit d deficiency rickets, dec PRODUCTION, give vit d and calcitriol
type ii - hereditary vit d RESISTANT rickets, problems with receptor, give LARGE DOSES of calcitriol and calcium and po4 infusions
normal serum calcium and pth BUT
hypercalciuria and nephrolithiaisis
idiopathic hypercalciuria
idiopathoc hypercalciuria tx
hydrochlorothiazide or ALLOPURINOL
short bowel syndrome with fat malabsorption, with ca and oxalate renal stones
enteric oxaluria
enteric oxaluria etiology
calcium bound to fat fails to bind to oxalate
poorly organized bone, elevated ALK PHOSPHATASE and urinary HYDROXYPROLINE
pagets disease of the bone
pagets dse of the bone tx
first line CALCITONIN and BISPHOSPHONATES, requiring weeks to months
treatment failures PLICAMYCIN
etidronate adverse effects
osteomalacia
inc risk of fractures
alendronate adverse effects
gastric irritation, but reversible